Global Anti-Retroviral Drugs Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Anti-Retroviral Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Anti-Retroviral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Protease Inhibitors
  • 1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors
  • 1.2.4 Integrase Inhibitors
  • 1.2.5 Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
• 1.3 Market by Application
  • 1.3.1 Global Anti-Retroviral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hepatitis
  • 1.3.3 HIV/AIDS
  • 1.3.4 Herpes
  • 1.3.5 Influenza
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Anti-Retroviral Drugs Sales Estimates and Forecasts 2017-2028
• 2.2 Global Anti-Retroviral Drugs Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Anti-Retroviral Drugs Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Anti-Retroviral Drugs Sales by Region
  • 2.4.1 Global Anti-Retroviral Drugs Sales by Region (2017-2022)
  • 2.4.2 Global Sales Anti-Retroviral Drugs by Region (2023-2028)
• 2.5 Global Anti-Retroviral Drugs Revenue by Region
  • 2.5.1 Global Anti-Retroviral Drugs Revenue by Region (2017-2022)
  • 2.5.2 Global Anti-Retroviral Drugs Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Anti-Retroviral Drugs Sales by Manufacturers
  • 3.1.1 Global Top Anti-Retroviral Drugs Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Anti-Retroviral Drugs Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Retroviral Drugs in 2021
• 3.2 Global Anti-Retroviral Drugs Revenue by Manufacturers
  • 3.2.1 Global Anti-Retroviral Drugs Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Anti-Retroviral Drugs Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Anti-Retroviral Drugs Revenue in 2021
• 3.3 Global Anti-Retroviral Drugs Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Anti-Retroviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Anti-Retroviral Drugs Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Anti-Retroviral Drugs Sales by Type
  • 4.1.1 Global Anti-Retroviral Drugs Historical Sales by Type (2017-2022)
  • 4.1.2 Global Anti-Retroviral Drugs Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Anti-Retroviral Drugs Sales Market Share by Type (2017-2028)
• 4.2 Global Anti-Retroviral Drugs Revenue by Type
  • 4.2.1 Global Anti-Retroviral Drugs Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Anti-Retroviral Drugs Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Anti-Retroviral Drugs Revenue Market Share by Type (2017-2028)
• 4.3 Global Anti-Retroviral Drugs Price by Type
  • 4.3.1 Global Anti-Retroviral Drugs Price by Type (2017-2022)
  • 4.3.2 Global Anti-Retroviral Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Anti-Retroviral Drugs Sales by Application
  • 5.1.1 Global Anti-Retroviral Drugs Historical Sales by Application (2017-2022)
  • 5.1.2 Global Anti-Retroviral Drugs Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Anti-Retroviral Drugs Sales Market Share by Application (2017-2028)
• 5.2 Global Anti-Retroviral Drugs Revenue by Application
  • 5.2.1 Global Anti-Retroviral Drugs Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Anti-Retroviral Drugs Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Anti-Retroviral Drugs Revenue Market Share by Application (2017-2028)
• 5.3 Global Anti-Retroviral Drugs Price by Application
  • 5.3.1 Global Anti-Retroviral Drugs Price by Application (2017-2022)
  • 5.3.2 Global Anti-Retroviral Drugs Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Anti-Retroviral Drugs Market Size by Type
  • 6.1.1 North America Anti-Retroviral Drugs Sales by Type (2017-2028)
  • 6.1.2 North America Anti-Retroviral Drugs Revenue by Type (2017-2028)
• 6.2 North America Anti-Retroviral Drugs Market Size by Application
  • 6.2.1 North America Anti-Retroviral Drugs Sales by Application (2017-2028)
  • 6.2.2 North America Anti-Retroviral Drugs Revenue by Application (2017-2028)
• 6.3 North America Anti-Retroviral Drugs Market Size by Country
  • 6.3.1 North America Anti-Retroviral Drugs Sales by Country (2017-2028)
  • 6.3.2 North America Anti-Retroviral Drugs Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Anti-Retroviral Drugs Market Size by Type
  • 7.1.1 Europe Anti-Retroviral Drugs Sales by Type (2017-2028)
  • 7.1.2 Europe Anti-Retroviral Drugs Revenue by Type (2017-2028)
• 7.2 Europe Anti-Retroviral Drugs Market Size by Application
  • 7.2.1 Europe Anti-Retroviral Drugs Sales by Application (2017-2028)
  • 7.2.2 Europe Anti-Retroviral Drugs Revenue by Application (2017-2028)
• 7.3 Europe Anti-Retroviral Drugs Market Size by Country
  • 7.3.1 Europe Anti-Retroviral Drugs Sales by Country (2017-2028)
  • 7.3.2 Europe Anti-Retroviral Drugs Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Anti-Retroviral Drugs Market Size by Type
  • 8.1.1 Asia Pacific Anti-Retroviral Drugs Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Anti-Retroviral Drugs Revenue by Type (2017-2028)
• 8.2 Asia Pacific Anti-Retroviral Drugs Market Size by Application
  • 8.2.1 Asia Pacific Anti-Retroviral Drugs Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Anti-Retroviral Drugs Revenue by Application (2017-2028)
• 8.3 Asia Pacific Anti-Retroviral Drugs Market Size by Region
  • 8.3.1 Asia Pacific Anti-Retroviral Drugs Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Anti-Retroviral Drugs Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Anti-Retroviral Drugs Market Size by Type
  • 9.1.1 Latin America Anti-Retroviral Drugs Sales by Type (2017-2028)
  • 9.1.2 Latin America Anti-Retroviral Drugs Revenue by Type (2017-2028)
• 9.2 Latin America Anti-Retroviral Drugs Market Size by Application
  • 9.2.1 Latin America Anti-Retroviral Drugs Sales by Application (2017-2028)
  • 9.2.2 Latin America Anti-Retroviral Drugs Revenue by Application (2017-2028)
• 9.3 Latin America Anti-Retroviral Drugs Market Size by Country
  • 9.3.1 Latin America Anti-Retroviral Drugs Sales by Country (2017-2028)
  • 9.3.2 Latin America Anti-Retroviral Drugs Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Anti-Retroviral Drugs Market Size by Type
  • 10.1.1 Middle East and Africa Anti-Retroviral Drugs Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Anti-Retroviral Drugs Market Size by Application
  • 10.2.1 Middle East and Africa Anti-Retroviral Drugs Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Anti-Retroviral Drugs Market Size by Country
  • 10.3.1 Middle East and Africa Anti-Retroviral Drugs Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Cardionet
  • 11.1.1 Cardionet Corporation Information
  • 11.1.2 Cardionet Overview
  • 11.1.3 Cardionet Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Cardionet Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Cardionet Recent Developments
• 11.2 GE Healthcare
  • 11.2.1 GE Healthcare Corporation Information
  • 11.2.2 GE Healthcare Overview
  • 11.2.3 GE Healthcare Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 GE Healthcare Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 GE Healthcare Recent Developments
• 11.3 Abbott
  • 11.3.1 Abbott Corporation Information
  • 11.3.2 Abbott Overview
  • 11.3.3 Abbott Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Abbott Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Abbott Recent Developments
• 11.4 AstraZeneca
  • 11.4.1 AstraZeneca Corporation Information
  • 11.4.2 AstraZeneca Overview
  • 11.4.3 AstraZeneca Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 AstraZeneca Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 AstraZeneca Recent Developments
• 11.5 Bristol-Myers-Squibb
  • 11.5.1 Bristol-Myers-Squibb Corporation Information
  • 11.5.2 Bristol-Myers-Squibb Overview
  • 11.5.3 Bristol-Myers-Squibb Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Bristol-Myers-Squibb Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Bristol-Myers-Squibb Recent Developments
• 11.6 Gilead
  • 11.6.1 Gilead Corporation Information
  • 11.6.2 Gilead Overview
  • 11.6.3 Gilead Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Gilead Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Gilead Recent Developments
• 11.7 Cardiac Science Corp.
  • 11.7.1 Cardiac Science Corp. Corporation Information
  • 11.7.2 Cardiac Science Corp. Overview
  • 11.7.3 Cardiac Science Corp. Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Cardiac Science Corp. Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Cardiac Science Corp. Recent Developments
• 11.8 Cardiocom
  • 11.8.1 Cardiocom Corporation Information
  • 11.8.2 Cardiocom Overview
  • 11.8.3 Cardiocom Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Cardiocom Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Cardiocom Recent Developments
• 11.9 Biotelemetry
  • 11.9.1 Biotelemetry Corporation Information
  • 11.9.2 Biotelemetry Overview
  • 11.9.3 Biotelemetry Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Biotelemetry Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Biotelemetry Recent Developments
• 11.10 GlaxoSmithKline
  • 11.10.1 GlaxoSmithKline Corporation Information
  • 11.10.2 GlaxoSmithKline Overview
  • 11.10.3 GlaxoSmithKline Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 GlaxoSmithKline Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 GlaxoSmithKline Recent Developments
• 11.11 Roche
  • 11.11.1 Roche Corporation Information
  • 11.11.2 Roche Overview
  • 11.11.3 Roche Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 Roche Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Roche Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Anti-Retroviral Drugs Industry Chain Analysis
• 12.2 Anti-Retroviral Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Anti-Retroviral Drugs Production Mode & Process
• 12.4 Anti-Retroviral Drugs Sales and Marketing
  • 12.4.1 Anti-Retroviral Drugs Sales Channels
  • 12.4.2 Anti-Retroviral Drugs Distributors
• 12.5 Anti-Retroviral Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Anti-Retroviral Drugs Industry Trends
• 13.2 Anti-Retroviral Drugs Market Drivers
• 13.3 Anti-Retroviral Drugs Market Challenges
• 13.4 Anti-Retroviral Drugs Market Restraints

14 Key Findings in The Global Anti-Retroviral Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Anti-Retroviral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Protease Inhibitors
• Table 3. Major Manufacturers of Non-Nucleoside Reverse Transcriptase Inhibitors
• Table 4. Major Manufacturers of Integrase Inhibitors
• Table 5. Major Manufacturers of Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
• Table 6. Global Anti-Retroviral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 7. Global Anti-Retroviral Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 8. Global Anti-Retroviral Drugs Sales by Region (2017-2022) & (K Pcs)
• Table 9. Global Anti-Retroviral Drugs Sales Market Share by Region (2017-2022)
• Table 10. Global Anti-Retroviral Drugs Sales by Region (2023-2028) & (K Pcs)
• Table 11. Global Anti-Retroviral Drugs Sales Market Share by Region (2023-2028)
• Table 12. Global Anti-Retroviral Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 13. Global Anti-Retroviral Drugs Revenue Market Share by Region (2017-2022)
• Table 14. Global Anti-Retroviral Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 15. Global Anti-Retroviral Drugs Revenue Market Share by Region (2023-2028)
• Table 16. Global Anti-Retroviral Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
• Table 17. Global Anti-Retroviral Drugs Sales Share by Manufacturers (2017-2022)
• Table 18. Global Anti-Retroviral Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 19. Global Anti-Retroviral Drugs Revenue Share by Manufacturers (2017-2022)
• Table 20. Anti-Retroviral Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
• Table 21. Global Anti-Retroviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global Anti-Retroviral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Retroviral Drugs as of 2021)
• Table 23. Anti-Retroviral Drugs Manufacturing Base Distribution and Headquarters
• Table 24. Manufacturers Anti-Retroviral Drugs Product Offered
• Table 25. Date of Manufacturers Enter into Anti-Retroviral Drugs Market
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Anti-Retroviral Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 28. Global Anti-Retroviral Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 29. Global Anti-Retroviral Drugs Sales Share by Type (2017-2022)
• Table 30. Global Anti-Retroviral Drugs Sales Share by Type (2023-2028)
• Table 31. Global Anti-Retroviral Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 32. Global Anti-Retroviral Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 33. Global Anti-Retroviral Drugs Revenue Share by Type (2017-2022)
• Table 34. Global Anti-Retroviral Drugs Revenue Share by Type (2023-2028)
• Table 35. Anti-Retroviral Drugs Price by Type (2017-2022) & (USD/Pcs)
• Table 36. Global Anti-Retroviral Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
• Table 37. Global Anti-Retroviral Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 38. Global Anti-Retroviral Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 39. Global Anti-Retroviral Drugs Sales Share by Application (2017-2022)
• Table 40. Global Anti-Retroviral Drugs Sales Share by Application (2023-2028)
• Table 41. Global Anti-Retroviral Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 42. Global Anti-Retroviral Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 43. Global Anti-Retroviral Drugs Revenue Share by Application (2017-2022)
• Table 44. Global Anti-Retroviral Drugs Revenue Share by Application (2023-2028)
• Table 45. Anti-Retroviral Drugs Price by Application (2017-2022) & (USD/Pcs)
• Table 46. Global Anti-Retroviral Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
• Table 47. North America Anti-Retroviral Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 48. North America Anti-Retroviral Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 49. North America Anti-Retroviral Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 50. North America Anti-Retroviral Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 51. North America Anti-Retroviral Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 52. North America Anti-Retroviral Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 53. North America Anti-Retroviral Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 54. North America Anti-Retroviral Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 55. North America Anti-Retroviral Drugs Sales by Country (2017-2022) & (K Pcs)
• Table 56. North America Anti-Retroviral Drugs Sales by Country (2023-2028) & (K Pcs)
• Table 57. North America Anti-Retroviral Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 58. North America Anti-Retroviral Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 59. Europe Anti-Retroviral Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 60. Europe Anti-Retroviral Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 61. Europe Anti-Retroviral Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 62. Europe Anti-Retroviral Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 63. Europe Anti-Retroviral Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 64. Europe Anti-Retroviral Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 65. Europe Anti-Retroviral Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 66. Europe Anti-Retroviral Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 67. Europe Anti-Retroviral Drugs Sales by Country (2017-2022) & (K Pcs)
• Table 68. Europe Anti-Retroviral Drugs Sales by Country (2023-2028) & (K Pcs)
• Table 69. Europe Anti-Retroviral Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 70. Europe Anti-Retroviral Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 71. Asia Pacific Anti-Retroviral Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 72. Asia Pacific Anti-Retroviral Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 73. Asia Pacific Anti-Retroviral Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 74. Asia Pacific Anti-Retroviral Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 75. Asia Pacific Anti-Retroviral Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 76. Asia Pacific Anti-Retroviral Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 77. Asia Pacific Anti-Retroviral Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 78. Asia Pacific Anti-Retroviral Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 79. Asia Pacific Anti-Retroviral Drugs Sales by Region (2017-2022) & (K Pcs)
• Table 80. Asia Pacific Anti-Retroviral Drugs Sales by Region (2023-2028) & (K Pcs)
• Table 81. Asia Pacific Anti-Retroviral Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 82. Asia Pacific Anti-Retroviral Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 83. Latin America Anti-Retroviral Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 84. Latin America Anti-Retroviral Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 85. Latin America Anti-Retroviral Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 86. Latin America Anti-Retroviral Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 87. Latin America Anti-Retroviral Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 88. Latin America Anti-Retroviral Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 89. Latin America Anti-Retroviral Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 90. Latin America Anti-Retroviral Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 91. Latin America Anti-Retroviral Drugs Sales by Country (2017-2022) & (K Pcs)
• Table 92. Latin America Anti-Retroviral Drugs Sales by Country (2023-2028) & (K Pcs)
• Table 93. Latin America Anti-Retroviral Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 94. Latin America Anti-Retroviral Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 95. Middle East and Africa Anti-Retroviral Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 96. Middle East and Africa Anti-Retroviral Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 97. Middle East and Africa Anti-Retroviral Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 98. Middle East and Africa Anti-Retroviral Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 99. Middle East and Africa Anti-Retroviral Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 100. Middle East and Africa Anti-Retroviral Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 101. Middle East and Africa Anti-Retroviral Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 102. Middle East and Africa Anti-Retroviral Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 103. Middle East and Africa Anti-Retroviral Drugs Sales by Country (2017-2022) & (K Pcs)
• Table 104. Middle East and Africa Anti-Retroviral Drugs Sales by Country (2023-2028) & (K Pcs)
• Table 105. Middle East and Africa Anti-Retroviral Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 106. Middle East and Africa Anti-Retroviral Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 107. Cardionet Corporation Information
• Table 108. Cardionet Description and Major Businesses
• Table 109. Cardionet Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 110. Cardionet Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. Cardionet Recent Developments
• Table 112. GE Healthcare Corporation Information
• Table 113. GE Healthcare Description and Major Businesses
• Table 114. GE Healthcare Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 115. GE Healthcare Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. GE Healthcare Recent Developments
• Table 117. Abbott Corporation Information
• Table 118. Abbott Description and Major Businesses
• Table 119. Abbott Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 120. Abbott Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. Abbott Recent Developments
• Table 122. AstraZeneca Corporation Information
• Table 123. AstraZeneca Description and Major Businesses
• Table 124. AstraZeneca Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 125. AstraZeneca Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. AstraZeneca Recent Developments
• Table 127. Bristol-Myers-Squibb Corporation Information
• Table 128. Bristol-Myers-Squibb Description and Major Businesses
• Table 129. Bristol-Myers-Squibb Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 130. Bristol-Myers-Squibb Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. Bristol-Myers-Squibb Recent Developments
• Table 132. Gilead Corporation Information
• Table 133. Gilead Description and Major Businesses
• Table 134. Gilead Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 135. Gilead Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Gilead Recent Developments
• Table 137. Cardiac Science Corp. Corporation Information
• Table 138. Cardiac Science Corp. Description and Major Businesses
• Table 139. Cardiac Science Corp. Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 140. Cardiac Science Corp. Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Cardiac Science Corp. Recent Developments
• Table 142. Cardiocom Corporation Information
• Table 143. Cardiocom Description and Major Businesses
• Table 144. Cardiocom Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 145. Cardiocom Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. Cardiocom Recent Developments
• Table 147. Biotelemetry Corporation Information
• Table 148. Biotelemetry Description and Major Businesses
• Table 149. Biotelemetry Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 150. Biotelemetry Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. Biotelemetry Recent Developments
• Table 152. GlaxoSmithKline Corporation Information
• Table 153. GlaxoSmithKline Description and Major Businesses
• Table 154. GlaxoSmithKline Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 155. GlaxoSmithKline Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. GlaxoSmithKline Recent Developments
• Table 157. Roche Corporation Information
• Table 158. Roche Description and Major Businesses
• Table 159. Roche Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 160. Roche Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 161. Roche Recent Developments
• Table 162. Key Raw Materials Lists
• Table 163. Raw Materials Key Suppliers Lists
• Table 164. Anti-Retroviral Drugs Distributors List
• Table 165. Anti-Retroviral Drugs Customers List
• Table 166. Anti-Retroviral Drugs Market Trends
• Table 167. Anti-Retroviral Drugs Market Drivers
• Table 168. Anti-Retroviral Drugs Market Challenges
• Table 169. Anti-Retroviral Drugs Market Restraints
• Table 170. Research Programs/Design for This Report
• Table 171. Key Data Information from Secondary Sources
• Table 172. Key Data Information from Primary Sources

List of Figures

• Figure 1. Anti-Retroviral Drugs Product Picture
• Figure 3. Global Anti-Retroviral Drugs Market Share by Type in 2021 & 2028
• Figure 3. Protease Inhibitors Product Picture
• Figure 4. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
• Figure 5. Integrase Inhibitors Product Picture
• Figure 6. Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Product Picture
• Figure 7. Global Anti-Retroviral Drugs Market Share by Application in 2021 & 2028
• Figure 8. Hepatitis
• Figure 9. HIV/AIDS
• Figure 10. Herpes
• Figure 11. Influenza
• Figure 12. Others
• Figure 13. Anti-Retroviral Drugs Report Years Considered
• Figure 14. Global Anti-Retroviral Drugs Sales 2017-2028 (K Pcs)
• Figure 15. Global Anti-Retroviral Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 16. Global Anti-Retroviral Drugs Revenue 2017-2028 (US$ Million)
• Figure 17. Global Anti-Retroviral Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 18. Global Anti-Retroviral Drugs Sales Market Share by Region (2017-2022)
• Figure 19. Global Anti-Retroviral Drugs Sales Market Share by Region (2023-2028)
• Figure 20. North America Anti-Retroviral Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 21. North America Anti-Retroviral Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Europe Anti-Retroviral Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 23. Europe Anti-Retroviral Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Asia-Pacific Anti-Retroviral Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 25. Asia-Pacific Anti-Retroviral Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. Latin America Anti-Retroviral Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 27. Latin America Anti-Retroviral Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 28. Middle East & Africa Anti-Retroviral Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 29. Middle East & Africa Anti-Retroviral Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 30. The Anti-Retroviral Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 31. The Top 5 and 10 Largest Manufacturers of Anti-Retroviral Drugs in the World: Market Share by Anti-Retroviral Drugs Revenue in 2021
• Figure 32. Global Anti-Retroviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 33. Global Anti-Retroviral Drugs Sales Market Share by Type (2017-2028)
• Figure 34. Global Anti-Retroviral Drugs Revenue Market Share by Type (2017-2028)
• Figure 35. Global Anti-Retroviral Drugs Sales Market Share by Application (2017-2028)
• Figure 36. Global Anti-Retroviral Drugs Revenue Market Share by Application (2017-2028)
• Figure 37. North America Anti-Retroviral Drugs Sales Market Share by Type (2017-2028)
• Figure 38. North America Anti-Retroviral Drugs Revenue Market Share by Type (2017-2028)
• Figure 39. North America Anti-Retroviral Drugs Sales Market Share by Application (2017-2028)
• Figure 40. North America Anti-Retroviral Drugs Revenue Market Share by Application (2017-2028)
• Figure 41. North America Anti-Retroviral Drugs Sales Share by Country (2017-2028)
• Figure 42. North America Anti-Retroviral Drugs Revenue Share by Country (2017-2028)
• Figure 43. U.S. Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 44. Canada Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 45. Europe Anti-Retroviral Drugs Sales Market Share by Type (2017-2028)
• Figure 46. Europe Anti-Retroviral Drugs Revenue Market Share by Type (2017-2028)
• Figure 47. Europe Anti-Retroviral Drugs Sales Market Share by Application (2017-2028)
• Figure 48. Europe Anti-Retroviral Drugs Revenue Market Share by Application (2017-2028)
• Figure 49. Europe Anti-Retroviral Drugs Sales Share by Country (2017-2028)
• Figure 50. Europe Anti-Retroviral Drugs Revenue Share by Country (2017-2028)
• Figure 51. Germany Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 52. France Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 53. U.K. Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 54. Italy Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 55. Russia Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 56. Asia Pacific Anti-Retroviral Drugs Sales Market Share by Type (2017-2028)
• Figure 57. Asia Pacific Anti-Retroviral Drugs Revenue Market Share by Type (2017-2028)
• Figure 58. Asia Pacific Anti-Retroviral Drugs Sales Market Share by Application (2017-2028)
• Figure 59. Asia Pacific Anti-Retroviral Drugs Revenue Market Share by Application (2017-2028)
• Figure 60. Asia Pacific Anti-Retroviral Drugs Sales Share by Region (2017-2028)
• Figure 61. Asia Pacific Anti-Retroviral Drugs Revenue Share by Region (2017-2028)
• Figure 62. China Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 63. Japan Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 64. South Korea Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 65. India Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 66. Australia Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 67. Taiwan Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 68. Indonesia Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 69. Thailand Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 70. Malaysia Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 71. Philippines Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 72. Latin America Anti-Retroviral Drugs Sales Market Share by Type (2017-2028)
• Figure 73. Latin America Anti-Retroviral Drugs Revenue Market Share by Type (2017-2028)
• Figure 74. Latin America Anti-Retroviral Drugs Sales Market Share by Application (2017-2028)
• Figure 75. Latin America Anti-Retroviral Drugs Revenue Market Share by Application (2017-2028)
• Figure 76. Latin America Anti-Retroviral Drugs Sales Share by Country (2017-2028)
• Figure 77. Latin America Anti-Retroviral Drugs Revenue Share by Country (2017-2028)
• Figure 78. Mexico Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 79. Brazil Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 80. Argentina Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 81. Middle East and Africa Anti-Retroviral Drugs Sales Market Share by Type (2017-2028)
• Figure 82. Middle East and Africa Anti-Retroviral Drugs Revenue Market Share by Type (2017-2028)
• Figure 83. Middle East and Africa Anti-Retroviral Drugs Sales Market Share by Application (2017-2028)
• Figure 84. Middle East and Africa Anti-Retroviral Drugs Revenue Market Share by Application (2017-2028)
• Figure 85. Middle East and Africa Anti-Retroviral Drugs Sales Share by Country (2017-2028)
• Figure 86. Middle East and Africa Anti-Retroviral Drugs Revenue Share by Country (2017-2028)
• Figure 87. Turkey Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 88. Saudi Arabia Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 89. UAE Anti-Retroviral Drugs Revenue (2017-2028) & (US$ Million)
• Figure 90. Anti-Retroviral Drugs Value Chain
• Figure 91. Anti-Retroviral Drugs Production Process
• Figure 92. Channels of Distribution
• Figure 93. Distributors Profiles
• Figure 94. Bottom-up and Top-down Approaches for This Report
• Figure 95. Data Triangulation
• Figure 96. Key Executives Interviewed